The voice for compounding pharmacy  |  November 15, 2019
Enjoy our latest edition. Send your suggestions and questions to  [email protected] .
From IACP's President...
10 things you need to know (or do) right now :
  1. Vote. As you'll read below, you only have one more week to vote in IACP board of directors elections and on bylaws amendments that, among other things, will change our name.
  2. Embrace patient safety. As you'll read below, our new collaboration with the Alliance for Patient Medication Safety gives you access to tools and techniques that help you put patient safety first in your pharmacy - and provide you a level of legal protection at the same time.
  3. Share cBHRT outcomes data with NASEM. The info-gathering phase of NASEM's FDA-funded study of cBHRT is coming to a close, but there's still time for you to write to the NASEM committee to share data about results you and your prescriber partners are achieving with cBHRT. If you've got compelling data, let us know, and we can help make sure the committee receives it.
  4. Support savemycompounds.comIt's a grassroots effort that helps patients who benefit from compounding reach out to members of Congress to urge their support of a workable MOU with states (one that doesn't limit patient access) and the continued ability of compounders to provide BHRT therapy. To-date, almost 30,000 patient messages have been sent to members of Congress. You can help by making your patients aware of the initiative.
  5. Schedule pharmacy visits. As we approach holidays and year-end, there's a good chance your members of Congress will be home in their district - the perfect time for you to host them at your pharmacy, allow them to see what you do and how you do it, and discuss the challenges compounders are facing. It's as easy as calling your Congressperson's district office and scheduling a date. And without a doubt it's the very best way to educate elected officials on compounding policy priorities. (If you need help with talking points, email [email protected].)
  6. Do your part for OneFund. In our last issue, I wrote of the importance of investing in OneFund, which fuels our advocacy efforts. If you like what we're doing in appealing USP BUD restrictions, working with FDA on the MOU, and advising NASEM on the patient results pharmacists are achieving with cBHRT, then help support those efforts. As I wrote last time, funds are running low. Here's how to do your part.
  7. Wrap-up your CE credits. As we near year-end, it's a good time to make sure you have the requisite CE to satisfy your state's requirements. IACP can help. As you'll read below, not only are we offering a great webinar about CBD on December 10, but we have a whole catalog of great sessions you can take advantage of to meet your state's requirements.
  8. Mark your calendar: EduCon 2020 registration opens December 2. The event is April 6-9 in Denver. If you register before December 31, you'll save $100. Details below. (And note: This year you'll not be able to make your hotel reservation at the preferred rate until you've formally registered for the conference.)
  9. Our Stateside Coalition is growing. Last week we added two new reps - one from Hawaii, one from Delaware - to our coalition of compounders who've volunteered to be IACP's eyes and ears and voice at their state's Board of Pharmacy meetings. We're working to have coverage in all 50 states. Interested? Contact [email protected].
  10. Help amplify the voice of pharmacy compounding. In coming weeks we'll debut a new name, a new look, and a new website to match the new energy and vision you're seeing from IACP. Help us grow our membership and amplify the voice of pharmacy compounding, too. Urge your pharmacy team members to join us. And if you're an owner, why not consider subsidizing your team members' IACP dues? We NEED those folks ... and we need your help in encouraging them to belong. Here's how to join online.
That's my first-ever Top 10 List - and you'll find plenty more good stuff below!

Cheers!

Jennifer Burch, PharmD, RPh, CDE
President
USP posts FAQ about <795> and <797> appeals
On November 4 USP released a FAQ on Compounding Appeals  on the website.  Additional information from USP may be found here Here are some more links to documents and other info about IACP's appeal and USP's postponement of the chapters - everything you need to know in one spot:
  1. IACP's initial reporting on the BUD date restrictions in <795> and <797>
  2. IACP's Appeal (with Wedgewood and Innovations Compounding)
  3. USP Compounding Expert Committee's notification of rejection of the appeal
  4. IACP's (and partners') request for hearing on the appeal
  5. USP's announcement of indefinite postponement of the chapters
  6. IACP's briefing paper for members and state boards of pharmacy
  7. IACP's CALL TO ACTION to members to urge state BOPs to express concerns to USP
New IACP benefit helps you get a handle on medication incidents
Do you know how many medication incidents occur in your pharmacy? Do you have tools to effectively manage and reduce them? 
 
IACP's new partnership with the Alliance for Patient Medication Safety can help. The APMSĀ® Patient Safety Organization helps you put safety at the center of your pharmacy operations. Get a handle on the inherent risks in your pharmacy's workflow and discover opportunities for improvement in a legally protected environment.

For less than a dollar a day you can access tools to improve workflow, enhance patient safety, train your team, and reduce risk.
Join here.
LAST CALL: Have you VOTED on our name change?
Voting on 2020 IACP Board of Directors and proposed bylaws amendments concludes next Friday, November 22 at noon EST. IACP members have received an email allowing them to access our voting portal. If you've not yet voted, get going -- you've only got another week.
 
 
EduCon 2020 registration opens December 1!

IACP members presented this week at NASEM cBHRT session
IACP member compounding pharmacists Gina Besteman of Women's International and Peter Koshland of Koshland Pharm: Custom Compounding Pharmacy this week made presentations at a hearing on cBHRT at the National Academies of Science, Engineering and Medicine in Washington, DC. The NASEM hearing was the result of a request by IACP, NCPA and APhA that NASEM seek broader input from cBHRT prescribers and practitioners to inform its FDA-funded study on the clinical utility of cBHRT. Committee members asked a number of follow-up questions for Besteman and Koshland as they sought to understand best practices related to dispensing cBHRT. NCPA's Ronna Hauser and APhA CEO Tom Menighan also presented at the session.


Photo o' the week

Tantalizing tidbit:
Congresswoman Madeleine Dean visits Advanced Rx
IACP member Jason Jerusik and staff welcomed Congresswoman Madeleine Dean and her staffer Matt Bieber to Advanced Rx in Plymouth Meeting, PA last week.  Congresswoman Dean spoke with staff and toured the pharmacy. The team provided background on the MOU, distribute vs. dispense, the proposed 5% cap and how that will negatively impact patient access and the pharmacy.  Thank you to Congresswoman Dean and the team at Advanced Rx for promoting compounding.
Have you used IACP's members-only compounding policy resources?
  • Compilation of State-Adopted USP 8=795-797-800 Rules 
Need to know which states have adopted which parts of USP chapters <795>, <797> or <800>? You'll find answers in our new "Compilation of State-Adopted USP 795, 797, 800 Rules."  Click here to access the resource.  
  • 'State Compounding for Office Use and Veterinary Office Use' Resource 
Need to know what a particular state's law or regulation has to say about office-use or veterinary compounding? You'll find answers in our 'State Compounding for Office Use and Veterinary Office Use' Resource, available at  www.iacprx.org/StateCompoundingLaw .
 
Both resources were created in collaboration with the National Alliance of State Pharmacy Associations and funded by generous grants from the IACP Foundation. Because both resources are for IACP members only, you are required to log-in to access them. If you need to renew your membership or are interested in joining IACP,  here's where to do that .
Free compounding policy briefing for student groups
IACP is offering pharmacy schools student groups a free hour-long Skype briefing called "Public Policy and Pharmacy Compounding" if the schools are willing to promote student memberships in IACP. Student dues are only $5. Contact   [email protected]  for details or to schedule a briefing.
These member benefits more than cover your dues
Are you taking advantage of our  members-only discounts  on a range of products and services that more than cover the costs of your annual IACP dues? Here's a short list:

  • NEW: The APMSĀ® Patient Safety Organization (PSO), helps you put safety at the center of your pharmacy operations. Get a handle on the inherent risks in your pharmacy's workflow and discover opportunities for improvement in a legally protected environment. Subscription information can be found here.
  • Get $500 off the cost of PCAB accreditation, the gold-standard certification for compounding pharmacies.
  • Get a no-cost, no obligation gap analysis of your business and liability insurance coverage via RiskAlert-Rx - a service specially designed to help IACP member owners better understand risks of loss, plus you'll get step-by-step solutions to address any deficiencies.
  • Save $200 on the registration for CBI's upcoming West Coast Compounding Compliance Conference. Details here.
  • Get 10% off $500 or more of marketing services from Storey Marketing. (Valid one time per pharmacy owner.)
Other stuff worth reading
If you want to protect your practice, here's how ...
Invest NOW in IACP's OneFund.  It's what fuels our advocacy efforts on your behalf, from our work on Capitol Hill to our work at FDA and USP. Your IACP dues alone are not enough to allow us to accomplish our mission. OneFund covers the costs of our lobbyist, attorneys and more.  PLEASE go  to  www.iacprx.org/onefund   and invest today.
Upcoming LIVE Webinar:
 
The CBD Arena: Pitfalls to Avoid
Tuesday, December 10, 2019
10:00 - 11:00 a.m. CST
Jeffrey S Baird, Esq.
Chairman, Health Care Group - Brown & Fortunato, P.C.
Bradley W. Howard
J.D. - Brown & Fortunato, P.C.

As is normally the case, the law is several years behind technological advancements. A case in point pertains to cannabidiol ("CBD"). Emerging evidence indicates that CBD has positive effects on a number of medical conditions. However, CBD has not been subjected to rigorous FDA-sanctioned clinical trials. While a number of states allow the sale of CBD for multiple uses, federal law remains restrictive. This program will discuss (i) federal and state laws pertaining to the sale of CBD,(ii) state law, specific to pharmacies, that is relevant to the sale of CBD by pharmacies, (iii) risks that pharmacies assume by selling CBD, and (iv) steps that pharmacies can take to reduce such risks.

Learning Objectives for Pharmacists and Technicians:

1. Describe the federal laws pertaining to the sale of CBD.
2. Recall the various state laws pertaining to the sale of CBD.
3. Outline the risks that pharmacies face in selling CBD.
4. Explain how the pharmacy can reduce risks arising from the sale of CBD.

And don't miss these pre-recorded  webinars, ready when you need them, from IACP:
 
These are perfect for self-paced learning. Click title for details.
IACP| 281.933.8400 | [email protected] | iacprx.org
STAY CONNECTED:

(C) IACP 2018